Company profile for CAMP4 Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CAMP4 is the culmination of months of pre-climb preparation and weeks of perseverance, endurance and ingenuity on the mountain. Others have gone before – some succeeded, many failed. The risks to reach the summit, while significant, are outweighed by the promise of the ultimate reward. Summiting Everest is one of the most arduous physical and mental challenges – and greatest feats .Our platform’s proprietary insights ena...
CAMP4 is the culmination of months of pre-climb preparation and weeks of perseverance, endurance and ingenuity on the mountain. Others have gone before – some succeeded, many failed. The risks to reach the summit, while significant, are outweighed by the promise of the ultimate reward. Summiting Everest is one of the most arduous physical and mental challenges – and greatest feats .Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Kendall Square Bldg 1400 West, 3rd Floor Cambridge, MA 02139
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/14/3188600/0/en/CAMP4-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
14 Nov 2025

https://www.fiercebiotech.com/biotech/sana-camp4-ditch-clinical-stage-assets-more-promising-preclinical-candidates

FIERCE BIOTECH
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183089/0/en/CAMP4-Reports-Third-Quarter-2025-Financial-Results-and-Corporate-Highlights.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/01/3159424/0/en/CAMP4-Therapeutics-Initiates-GLP-Toxicology-Studies-for-CMP-SYNGAP-01.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/09/10/3147616/0/en/CAMP4-Announces-an-Oversubscribed-Private-Placement-of-up-to-100-Million-to-Advance-First-in-Class-Treatment-for-SYNGAP1-Related-Disorders.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/08/14/3133850/0/en/CAMP4-Reports-Second-Quarter-2025-Financial-Results-and-Corporate-Highlights.html

GLOBENEWSWIRE
14 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty